A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383.

NCT04810676 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Type2 Diabetes Mellitus

Interventions

DRUG: CKD-501, D745, D150
DRUG: CKD-383

Sponsor

Chong Kun Dang Pharmaceutical